Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France
暂无分享,去创建一个
F. Tubach | A. Lafourcade | Y. De rycke | C. Bergeron | S. Guillo | A. Lajoinie | S. Bénard | X. Bresse | M. Dalichampt | M. Uhart | A. Dahlab | H. Borne | C. Cancalon | Y. de Rycke
[1] M. Zins,et al. Pap tests for cervical cancer screening test and contraception: analysis of data from the CONSTANCES cohort study , 2019, BMC Cancer.
[2] B. Trétarre,et al. [Implementation of National Cervical Cancer Screening Program in France]. , 2019, Bulletin du cancer.
[3] M. Moyal-Barracco,et al. Epidemiological and economic burden of potentially HPV-related cancers in France , 2018, PloS one.
[4] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[5] O. Picone. Herpès génital et grossesse : épidémiologie, manifestations de la maladie, prévention et dépistage. Recommandations pour la pratique clinique du Collège national des gynécologues obstétriciens français (CNGOF) , 2017 .
[6] M. Paraskevaidi,et al. Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease. , 2017, The Cochrane database of systematic reviews.
[7] M. Plummer,et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type , 2017, International journal of cancer.
[8] Nicholas Moore,et al. The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology , 2017, Pharmacoepidemiology and drug safety.
[9] F. Alla,et al. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study , 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[10] F. Bray,et al. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. , 2016, The Lancet. Global health.
[11] Ebenezer Tumban,et al. Gardasil-9: A global survey of projected efficacy. , 2016, Antiviral research.
[12] S. de Sanjosé,et al. Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: Potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines , 2015, Papillomavirus Research.
[13] M. Lapeyre-Mestre,et al. French health insurance databases: What interest for medical research? , 2015, La Revue de medecine interne.
[14] E. Unger,et al. Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States - 2008-2012. , 2015, Vaccine.
[15] P. Martin-Hirsch,et al. Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis , 2014, BMJ : British Medical Journal.
[16] S. Kjaer,et al. Early impact of human papillomavirus vaccination on cervical neoplasia--nationwide follow-up of young Danish women. , 2014, Journal of the National Cancer Institute.
[17] A. Woronoff,et al. [Obstetric outcomes following LOOP-excision]. , 2013, Journal de gynecologie, obstetrique et biologie de la reproduction.
[18] Cngof. [Prevention of the complications related to the use of prosthetic meshes in prolapse surgery: guidelines for clinical practice - text of the guidelines]. , 2011, Journal de gynecologie, obstetrique et biologie de la reproduction.
[19] A. Weill,et al. French national health insurance information system and the permanent beneficiaries sample. , 2010, Revue d'epidemiologie et de sante publique.
[20] P. Mathevet,et al. Vulvar and vaginal cancers and dysplasia in France--an analysis of the hospital medical information system (PMSI) database. , 2009, European journal of obstetrics, gynecology, and reproductive biology.
[21] Y. Robert,et al. Collège National des Gynécologues et Obstétriciens Français , 2008 .
[22] J. Charlot,et al. Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study , 2008, International journal of cancer.
[23] K. Straif,et al. Carcinogenicity of human papillomaviruses. , 2005, The Lancet. Oncology.
[24] Anaes. Conduite à tenir devant une patiente ayant un frottis cervico-utérin anormal - Actualisation 2002 , 2003 .
[25] A. Woronoff,et al. [Obstetric outcomes following LOOP-excision]. , 2013, Journal de gynecologie, obstetrique et biologie de la reproduction.
[26] Charlotte A Lee,et al. Human papillomavirus (HPV) and cervical cancer. , 2012, Journal of insurance medicine.
[27] ICD-9-CM Official Guidelines for Coding and Reporting , 2002 .
[28] P. Schaffer. Le dépistage du cancer du col de l'utérus en France , 1991 .